- Home
- INZY vs WIA Comparison
INZY vs WIA Comparison
Compare INZY & WIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INZY
- WIA
- Stock Information
- Founded
- INZY 2015
- WIA 2003
- Country
- INZY United States
- WIA United States
- Employees
- INZY N/A
- WIA N/A
- Industry
- INZY Biotechnology: Pharmaceutical Preparations
- WIA Trusts Except Educational Religious and Charitable
- Sector
- INZY Health Care
- WIA Finance
- Exchange
- INZY Nasdaq
- WIA Nasdaq
- Market Cap
- INZY 188.2M
- WIA 186.8M
- IPO Year
- INZY 2020
- WIA N/A
- Fundamental
- Price
- INZY $1.36
- WIA $8.22
- Analyst Decision
- INZY Strong Buy
- WIA
- Analyst Count
- INZY 8
- WIA 0
- Target Price
- INZY $17.75
- WIA N/A
- AVG Volume (30 Days)
- INZY 1.0M
- WIA 39.2K
- Earning Date
- INZY 03-11-2025
- WIA 01-01-0001
- Dividend Yield
- INZY N/A
- WIA 12.29%
- EPS Growth
- INZY N/A
- WIA N/A
- EPS
- INZY N/A
- WIA N/A
- Revenue
- INZY N/A
- WIA N/A
- Revenue This Year
- INZY N/A
- WIA N/A
- Revenue Next Year
- INZY N/A
- WIA N/A
- P/E Ratio
- INZY N/A
- WIA N/A
- Revenue Growth
- INZY N/A
- WIA N/A
- 52 Week Low
- INZY $1.24
- WIA $7.56
- 52 Week High
- INZY $7.80
- WIA $8.91
- Technical
- Relative Strength Index (RSI)
- INZY 29.28
- WIA 59.46
- Support Level
- INZY $1.35
- WIA $8.09
- Resistance Level
- INZY $1.62
- WIA $8.21
- Average True Range (ATR)
- INZY 0.13
- WIA 0.09
- MACD
- INZY 0.04
- WIA 0.02
- Stochastic Oscillator
- INZY 32.89
- WIA 73.33
About INZY Inozyme Pharma Inc.
Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.
About WIA Western Asset Inflation-Linked Income Fund
Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation.